Gene · 537
NIH grants1,040
NIH grants whose papers are about the gene, through NIH's grant-paper links.
21 to 40 of 1,040
Download this page as JSON| Grant | Title | ATP6AP1 papers | Newest fiscal year |
|---|---|---|---|
| P30GM124165 | NE-CAT: A Resource for Advanced Macromolecular Crystallography | 2 | 2025 |
| R01CA203348 | Expression of recombinant Fc receptors by engineered NK cells to enhance cancer cell killing | 2 | 2025 |
| R01GM086596 | Activation of androgen biosynthesis and drug metabolism by cytochrome b5 | 2 | 2025 |
| R01GM126048 | Regulation and function of the Hippo pathway in growth control | 2 | 2025 |
| R01NS074324 | Mechanisms of Novel Regulators of Proteotoxicity and Quality Control Associated with ALS/FTD | 2 | 2025 |
| R01NS089616 | Investigating the Novel Disease Pathways Associated with C9orf72-Linked ALS/FTD | 2 | 2025 |
| R01NS110098 | Investigating Dysregulation of Stress-related Ribonucleoprotein Granules and Functions of Associated RNA-binding Proteins in ALS/FTD | 2 | 2025 |
| R35GM122481 | Development and Testing of New Computational Methods for Ligand Discovery and Mechanism | 2 | 2025 |
| U19AI135972 | SARS-CoV adaptations through a Systems Biology Lens (SYBIL) | 2 | 2025 |
| UL1TR001866 | Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success | 2 | 2025 |
| ZIAAI000646 | Transgenic Animal Models Of Human Immune Defects | 2 | 2025 |
| ZIAAI000647 | Genes And Gene Products As Immunoadjuvants | 2 | 2025 |
| ZIABC006161 | DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs | 2 | 2025 |
| I01BX002466 | VA Biorepository Brain Bank | 1 | 2025 |
| K01MH129758 | A novel method to resolve the complex genome rearrangements of the large copy number variants (CNVs) associated with psychiatric disorders | 1 | 2025 |
| K08AI163369 | Modeling early SARS-CoV-2 pathogenesis in human lung organoids and slice cultures | 1 | 2025 |
| K12CA184746 | MSK Paul Calabresi Career Development Award for Clinical Oncology | 1 | 2025 |
| K24HL155861 | Prevention and Treatment of Cardiovascular Disease in Patients with Chronic Kidney Disease: Patient-Oriented Research and Mentoring | 1 | 2025 |
| KL2TR001865 | Institutional Career Development Core | 1 | 2025 |
| P01AG084497 | Mechanisms Underlying Heterogeneity of Cognitive Outcomes in Synucleinopathy | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/537/grants?page=2